Effects of Soluble Guanylate Cyclase Stimulators and Activators on Anti-Aggregatory Signalling in Patients with Coronary Artery Spasm

Effects of Soluble Guanylate Cyclase Stimulators and Activators on Anti-Aggregatory Signalling in Patients with Coronary Artery Spasm

Impairment of the nitric oxide/soluble guanylate cyclase (NO)/sGC) signalling cascade is associated with many forms of cardiovascular disease, resulting not only in compromised vasodilatation but also loss of anti-aggregatory homeostasis. Myocardial ischaemia, heart failure, and atrial fibrillation...

Full description

Bibliographic Details
Main Authors:	Armin Muminovic, Yuliy Y. Chirkov, John D. Horowitz
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	International Journal of Molecular Sciences
Subjects:	nitric oxide soluble guanylate cyclase riociguat cinaciguat platelet aggregation coronary artery spasm
Online Access:	https://www.mdpi.com/1422-0067/24/11/9273

Similar Items

Impairment of Anti-Aggregatory Responses to Nitric Oxide and Prostacyclin: Mechanisms and Clinical Implications in Cardiovascular Disease
by: Yuliy Y. Chirkov, et al.
Published: (2022-01-01)

Hydrogen sulfide regulates the redox state of soluble guanylate cyclase in CSE-/- mice corpus cavernosum microcirculation
by: Miguel A. Olivencia, et al.
Published: (2023-08-01)

Structural Perspectives on the Mechanism of Soluble Guanylate Cyclase Activation
by: Elizabeth C. Wittenborn, et al.
Published: (2021-05-01)

Soluble guanylate cyclase stimulators for heart failure: a network meta-analysis and subgroup analyses of reduced and preserved ejection fraction
by: Mohamed T. Abuelazm, et al.
Published: (2024-01-01)

Replacement of heme by soluble guanylate cyclase (sGC) activators abolishes heme-nitric oxide/oxygen (H-NOX) domain structural plasticity
by: Aikaterini I. Argyriou, et al.
Published: (2021-01-01)

Decoding signaling mechanisms: unraveling the targets of guanylate cyclase agonists in cardiovascular and digestive diseases
by: Qinan Yin, et al.
Published: (2023-12-01)

Soluble guanylate cyclase mediates the relaxation of healthy and inflamed bladder smooth muscle by aqueous nitric oxide
by: Patrik Aronsson, et al.
Published: (2023-09-01)

Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase
by: Arpeeta Sharma, et al.
Published: (2023-07-01)

The efficacy and safety of soluble guanylate cyclase modulation in patients with heart failure: a comprehensive meta-analysis of randomized controlled trials
by: Mehmet Emin Arayici, et al.
Published: (2024-03-01)

Soluble Guanylate Cyclase Stimulator Vericiguat Enhances Long-Term Memory in Rats without Altering Cerebral Blood Volume
by: Ellis Nelissen, et al.
Published: (2021-08-01)

Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts
by: Bianca Saveria Fioretto, et al.
Published: (2024-02-01)

Stimulation of soluble guanylate cyclase by vericiguat reduces skeletal muscle atrophy of mice following chemotherapy
by: Bo-ang Hu, et al.
Published: (2023-01-01)

Soluble Guanylyl Cyclase Activators—Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension
by: Grzegorz Grześk, et al.
Published: (2023-01-01)

Switching Strategy in the Management of Patients with Pulmonary Arterial Hypertension. The REPLACE Study Results
by: E. V. Filippov
Published: (2020-12-01)

Evaluating Riociguat in the Treatment of Pulmonary Arterial Hypertension: A Real-World Perspective
by: Mihalek AD, et al.
Published: (2022-10-01)

Infrared light elicits endothelium-dependent vasodilation in isolated occipital arteries of the rat via soluble guanylyl cyclase-dependent mechanisms
by: Tristan H. J. Lewis, et al.
Published: (2023-08-01)

Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC
by: Eva M. Becker-Pelster, et al.
Published: (2022-10-01)

The Transition of Photoreceptor Guanylate Cyclase Type 1 to the Active State
by: Manisha Kumari Shahu, et al.
Published: (2022-04-01)

Structural Insights into Retinal Guanylate Cyclase Activator Proteins (GCAPs)
by: James B. Ames
Published: (2021-08-01)

Current Modulation of Guanylate Cyclase Pathway Activity—Mechanism and Clinical Implications
by: Grzegorz Grześk, et al.
Published: (2021-06-01)

The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes
by: Irene Rosa, et al.
Published: (2022-12-01)

Age Impairs Soluble Guanylyl Cyclase Function in Mouse Mesenteric Arteries
by: Cheng Zhong, et al.
Published: (2021-10-01)

Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy
by: Stéphanie Guey, et al.
Published: (2023-03-01)

A Signaling Factor Linked to Toxoplasma gondii Guanylate Cyclase Complex Controls Invasion and Egress during Acute and Chronic Infection
by: Shu Ye, et al.
Published: (2022-10-01)

Distinct Pharmacological Properties of Gaseous CO and CO-Releasing Molecule in Human Platelets
by: Patrycja Kaczara, et al.
Published: (2021-03-01)

Molecular Properties of Human Guanylate Cyclase-Activating Protein 3 (GCAP3) and Its Possible Association with Retinitis Pigmentosa
by: Anna Avesani, et al.
Published: (2022-03-01)

Editorial: Multi-limbed membrane guanylate cyclase cellular signaling pathways
by: Rameshwar K. Sharma, et al.
Published: (2023-04-01)

Multilimbed membrane guanylate cyclase signaling system, evolutionary ladder
by: Teresa Duda, et al.
Published: (2023-01-01)

Guanylate cyclase-C Signaling Axis as a theragnostic target in colorectal cancer: a systematic review of literature
by: Moein Piroozkhah, et al.
Published: (2023-10-01)

Soluble Guanylate Cyclase Activators to Treat Benign Prostatic Hyperplasia and associated LUTS
by: A.J. Kanai, et al.
Published: (2023-06-01)

Retinal degeneration protein 3 controls membrane guanylate cyclase activities in brain tissue
by: Yaoyu Chen, et al.
Published: (2022-12-01)

Soluble Guanylate Cyclase Stimulators for Chronic Thromboembolic Pulmonary Hypertension Patients Treatment: New Data
by: M. A. Simakova, et al.
Published: (2020-05-01)

Vericiguat in Heart Failure: Characteristics, Scientific Evidence and Potential Clinical Applications
by: Francesca Vannuccini, et al.
Published: (2022-10-01)

Soluble guanylyl cyclase: Molecular basis for ligand selectivity and action in vitro and in vivo
by: Gang Wu, et al.
Published: (2022-10-01)

Atrial natriuretic factor receptor guanylate cyclase, ANF-RGC, transduces two independent signals, ANF and Ca2+
by: Teresa eDuda, et al.
Published: (2014-03-01)

Effect of Guanylate Cyclase-22-like on Ovarian Development of <i>Orius nagaii</i> (Hemiptera: Anthocoridae)
by: Huiling Du, et al.
Published: (2024-02-01)

The discovery of hidden guanylate cyclases (GCs) in the Homo sapiens proteome
by: Ilona Turek, et al.
Published: (2023-01-01)

Photoreceptor Guanylate Cyclase (GUCY2D) Mutations Cause Retinal Dystrophies by Severe Malfunction of Ca2+-Dependent Cyclic GMP Synthesis
by: Hanna Wimberg, et al.
Published: (2018-09-01)

Specific dilation pattern in placental circulation and the NO/sGC role in preeclampsia placental vessels
by: Jiaqi Tang, et al.
Published: (2023-05-01)

Membrane Guanylyl Cyclase Complexes Shape the Photoresponses of Retinal Rods and Cones
by: Xiao-Hong eWen, et al.
Published: (2014-06-01)